Mota, Jose Mauricio <br/><br/>
Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reports.  [electronic resource] 

 -  Medicine  Dec 2018 
 - e13517 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000013517  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Neoplasms--drug therapy<br/>Adrenocortical Carcinoma--drug therapy<br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>DNA Mismatch Repair--genetics<br/>Female<br/>Humans<br/>MutS Homolog 2 Protein--genetics<br/>Mutation<br/>Treatment Outcome